Related Experiment Video

Updated: Jan 1, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.3K

The potential of fecal microbiota transplantation in systemic sclerosis

Anna-Maria Hoffmann-Vold1,2, Håvard Fretheim1,2, Henriette Didriksen1,2

  • 1Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Expert Review of Clinical Immunology
|December 21, 2019
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Systemic sclerosisauto-immune diseasefecal microbiota transplantationgastrointestinal involvementmicrobiomeregulatory affairstreatment

More Related Videos

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.2K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.6K

Related Experiment Videos

Last Updated: Jan 1, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.3K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.2K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.6K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

423
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
423

Articles linked to this work by shared authors, journal, and citation graph.

Comorbidity and mortality in adults with juvenile idiopathic arthritis: a nationwide Norwegian register-based matched cohort study.

Rheumatology (Oxford, England)·2026

Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.

Annals of the rheumatic diseases·2026

Current Diagnostic Pathways for Rheumatoid Arthritis-Associated Interstitial Lung Disease Result in Substantial Underdiagnosis and Excess Mortality: A Multicenter Norwegian Quality Assurance Audit.

Joint bone spine·2026

Radiomic analysis of high-resolution computed tomography predicts interstitial lung disease progression and mortality in systemic sclerosis.

Rheumatology (Oxford, England)·2026

Diagnostic performance of lung ultrasound B-lines and serum KL-6 in detecting Sjögren's disease-related interstitial lung diseases.

Clinical rheumatology·2026

Treatment patterns, disease progression and survival in Sjögren disease-associated interstitial lung disease: a multicentre European cohort study.

Journal of autoimmunity·2026

SARS-CoV-2 management strategies in B-Cell-depleted people with multiple sclerosis: from prevention to antiviral treatment.

Expert review of clinical immunology·2026

Exploring novel and evolved tools in atopic dermatitis diagnosis.

Expert review of clinical immunology·2026

Atacicept in IgA nephropathy.

Expert review of clinical immunology·2026

Follicular lymphoma and the microenvironment: potential targets and biomarkers.

Expert review of clinical immunology·2026

Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review.

Expert review of clinical immunology·2026

Emerging treatment strategies in systemic lupus erythematosus: integrating molecular stratification, targeted therapy, and treatment response evaluation.

Expert review of clinical immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us